SecBot SecBot
425 ·Filed Oct 29, 2026

INDV

Indivior Pharmaceuticals, Inc.
BULLISH
Impact 5/10
Horizonimmediate Processed6d 13h ago SEC0001193125-26-436954
Rule 425 M&A communications
Actionable Insight ▲ Bullish

The merger closing on November 2 is the key catalyst; watch for the combined company's first post-merger guidance and any integration updates. The strong standalone results suggest Indivior enters the merger from a position of financial strength.

DirectionBullish
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK ABOVE ENTRY AT T+1
Entry
$35.25
T+0 close · Oct 29, 2026 · via day close
Latest settled
+0.34%
T+1 · $35.37 · next T+5 in 11h
vs SPY
+2.11%
α at T+1
Latest observation
+2.68%
T+2 · FF3 residual α
  1. T+0 · Oct 29 $35.25entry
  2. T+1 · 6d ago +0.34%α +2.11% · $35.37
  3. T+4 · todayOpen
  4. T+5 · in 11h Pending
  5. T+20 · in 22d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Indivior reported record Q3 2026 results with total net revenue up 13% YoY to $356M, record SUBLOCADE revenue up 22% YoY to $267M, and record adjusted EBITDA up 76% YoY to $211M. The merger with Supernus is on track to close November 2, 2026, with shareholder approval already obtained.

Key Financial Metrics

Deal Type
merger

Key Facts

  • Q3 2026 total net revenue of $356M, up 13% YoY from $314M
  • Record quarterly SUBLOCADE net revenue of $267M, up 22% YoY
  • Record GAAP net income of $137M ($1.12 diluted EPS) vs $42M ($0.33) in Q3 2025
  • Record adjusted EBITDA of $211M, up 76% YoY from $120M
  • Adjusted EBITDA margin of 59%, up 2,100 basis points YoY
  • Cash and investments of $332M at quarter end
  • Merger with Supernus expected to close November 2, 2026; combined company to trade as SUPN
  • Shareholders approved the merger in October 2026

Financial Impact

Revenue grew 13% YoY, net income more than tripled, adjusted EBITDA rose 76% YoY; merger closing within days

revenuenet incomeadjusted EBITDAcash position

Risk Factors

  • Post-merger integration execution risk with Supernus
  • Guidance will no longer apply after merger close, creating uncertainty around combined outlook
  • Special cash dividend contingent on closing adds leverage

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
90% bullish (10 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
425 Filing (Primary)0001193125-26-436954
Document: 0001193125-26-436954-index-headers.html0001193125-26-436954
Document: 0001193125-26-436954-index.html0001193125-26-436954
Document: 0001193125-26-436954.txt0001193125-26-436954
31 reports for INDV
Performance horizon
75% Hit rate @ T+5 6 of 8 bullish or bearish reports Went positive at some point 8 of 8 best @ T+60▲ +21.73%Apr 24, 2026
Filters
Rows
Reports for INDV, sortable and filterable
TypeNow
Nov 3, 2026
1d ago
8-K
NEUTRAL ★ 2/10
$35.43awaiting T+5awaiting T+5No price
Nov 2, 2026
2d ago
8-K
NEUTRAL ★ 5/10
$35.25awaiting T+5awaiting T+5No price
Oct 29, 2026
6d ago
425
BULLISH ★ 5/10
$35.25awaiting T+5awaiting T+5No price
Oct 29, 2026
6d ago
8-K
BULLISH ★ 5/10
No priceawaiting T+5awaiting T+5No price
Oct 29, 2026
6d ago
Press Release
NEUTRAL ★ 5/10
$35.25awaiting T+5awaiting T+5No price
Oct 20, 2026
15d ago
Institutional Cluster
BULLISH ★ 4/10
$34.79 $34.72▼ −0.20%▲ +0.24%No price
Oct 19, 2026
16d ago
Press Release
NEUTRAL ★ 1/10
$33.87awaiting T+5awaiting T+5No price
Oct 6, 2026
29d ago
425
NEUTRAL ★ 4/10
$35.90 $35.42▼ −1.34%▼ −1.20%No price
Oct 6, 2026
29d ago
8-K
NEUTRAL ★ 3/10
$35.90 $35.42▼ −1.34%▼ −1.20%No price
Sep 30, 2026
5w ago
SC 13G
NEUTRAL ★ 4/10
$35.38 $35.45▲ +0.20%▼ −1.10%No price
Showing 10 of 31

US Market Status

Market Closed · Opens Fri (13h 35m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 29, 2026